Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031
- Citation:
- Ann Oncol vol 22 (2) 348-354
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 532
- Children:
- None
- Pharmas:
- Grants:
- U10 CA 76001
- Corr. Author:
- Authors:
- V. J. Picozzi R. A. Abrams P. A. Decker W. Traverso E. M. O'Reilly E. Greeno R. C. Martin L. S. Wilfong M. L. Rothenberg M. C. Posner P. W. T. Pisters
- Networks:
- Study
- ACOSOG-Z05031
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- adenocarcinoma, chemoradiation, cisplatin, interferon, pancreas, surgery